mTOR Inhibitor-Corticoid Combination Therapy For Multiple Sclerosis

Bern University (2018). mTOR Inhibitor-Corticoid Combination Therapy For Multiple Sclerosis (WO 2018/153984 A1)

Full text not available from this repository. (Request a copy)

The invention relates to a combination medicament for the treatment or therapy of multiple sclerosis, which comprises a corticosteroid and an inhibitor of mTOR. The corticosteroid and the inhibitor of mTOR may both be administered by intravenous injection or by enteral administration, or by a combination of oral and parenteral administration. The combination medicament is useful for the treatment of patients suffering from multiple sclerosis that does not respond to corticosteroid monotherapy.

Item Type:

Patent

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Hoepner, Robert and Chan, Andrew

Subjects:

600 Technology > 610 Medicine & health

Publisher:

University of Bern

Language:

English

Submitter:

Panagiota Milona

Date Deposited:

28 Mar 2019 08:57

Last Modified:

28 Mar 2019 08:57

Related URLs:

URI:

https://boris.unibe.ch/id/eprint/125517

Actions (login required)

Edit item Edit item
Provide Feedback